| Symbol | FBLG |
|---|---|
| Name | FIBROBIOLOGICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 455 EAST MEDICAL CENTER BOULEVARD,SUITE 300,HOUSTON, TEXAS, Texas, 77598, United States |
| Telephone | 281 671 5150 |
| Fax | — |
| — | |
| Website | https://www.fibrobiologics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001958777 |
| Description | FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Additional info from NASDAQ: |
NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.
Read moreNASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.
Read moreNew Form PRE 14A - FibroBiologics, Inc. <b>Filed:</b> 2026-07-17 <b>AccNo:</b> 0001193125-26-307822 <b>Size:</b> 1 MB
Read moreNew Form EFFECT - FibroBiologics, Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 9999999995-26-002341 <b>Size:</b> 1 KB
Read moreNew Form 424B3 - FibroBiologics, Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001193125-26-306114 <b>Size:</b> 738 KB
Read moreNew Form 3 - FibroBiologics, Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001493152-26-033509 <b>Size:</b> 15 KB
Read moreFibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Read more(99% Neutral) FIBROBIOLOGICS, INC. (FBLG) Provides Update on exercise for full of warrantsHOUSTON
Read moreNew Form D - FibroBiologics, Inc. <b>Filed:</b> 2026-06-29 <b>AccNo:</b> 0001493152-26-031095 <b>Size:</b> 11 KB
Read more